spironolactone has been researched along with Lupus Erythematosus, Cutaneous in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leroy, D | 1 |
| Dompmartin, A | 1 |
| Le Jean, S | 1 |
| Guillemain, JL | 1 |
| Mandard, JC | 1 |
| Deschamps, P | 1 |
1 other study available for spironolactone and Lupus Erythematosus, Cutaneous
| Article | Year |
|---|---|
[Dermatitis caused by aldactone of a lupic annular erythema type].
Topics: Aged; Diagnosis, Differential; Drug Eruptions; Female; Humans; Lupus Erythematosus, Cutaneous; Pruri | 1987 |